Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02953652 · OUTCOME

Median Duration of Overall Survival (OS)

Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) · Source last updated 2024-09-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
Months
Interval / dispersion
95% Confidence Interval
Time frame
Up to approximately 55 months.

What was measured

Overall survival is defined as the duration from the first dose of study medication to death from any cause.

Analysis population: PPS - Per Protocol Set

Groups in this outcome

HBI-8000

HBI-8000 Tablets

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
HBI-800046

Reported measurements

Source class 1
Values in Months · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
HBI-800033.6Not reported16.5NANot estimable due to the low number of events
Complete source fields
classes
  1. categories
    1. measurements
      1. comment
        Not estimable due to the low number of events
        group Id
        OG000
        lower Limit
        16.5
        upper Limit
        NA
        value
        33.6
denoms
  1. counts
    1. group Id
      OG000
      value
      46
    units
    Participants
description
Overall survival is defined as the duration from the first dose of study medication to death from any cause.
dispersion Type
95% Confidence Interval
groups
  1. description
    HBI-8000 Tablets
    id
    OG000
    title
    HBI-8000
param Type
MEDIAN
population Description
PPS - Per Protocol Set
reporting Status
POSTED
time Frame
Up to approximately 55 months.
title
Median Duration of Overall Survival (OS)
type
OTHER_PRE_SPECIFIED
unit Of Measure
Months

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice